Atriva Therapeutics

Atriva Therapeutics, founded in 2015, is a biopharmaceutical company dedicated to pioneering the development of host-targeting antiviral therapies. Composed of leading scientists in virology research and seasoned industry experts, the company aims to develop novel antiviral treatments for various severe respiratory viral infections with significant unmet medical needs, such as influenza and COVID-19.